<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> is a rare adverse effect in <z:hpo ids='HP_0002861'>melanoma</z:hpo> patients elicited by chemotherapy </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> following treatment of <z:hpo ids='HP_0002861'>malignant melanoma</z:hpo> with <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Peripheral blood showed a remarkable suppression of three cell lineages, and the bone marrow was slightly hypercellular </plain></SENT>
<SENT sid="3" pm="."><plain>However, no morphological abnormalities were detected in the peripheral blood or the bone marrow, and chromosomal analysis was <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
</text></document>